National guidelines for diagnosis and treatment of lung cancer 2022 in China(English version)

摘要：

Contents
1.Overview
2.Screening and diagnosis
2.1 Risk factors for lung cancer
2.1.1 Smoking and involuntary smoking
2.1.2 History of chronic obstructive pulmonary disease(COPD)
2.1.3 Occupational exposures
2.1.4 Family history of lung cancer and genetic susceptibility
2.1.5 Other factors
2.2 Screening for high-risk population
2.3 Clinical manifestations
2.3.1 Symptoms arising from local growth of primary tumor itself
2.3.2 Symptoms of primary tumor invading adjacent organs and structures
2.3.3 Symptoms caused by distant metastasis of tumors
2.3.4 Extrapulmonary manifeestations of lung cancer
2.4 Physical examination
2.5 Accessory examination
2.5.1 Laboratory examination
2.5.2 Imaging examination
2.5.3 Endoscopy and other examinations
2.6 Histopathological examination
2.6.1 Diagnostic criteria
2.6.2 Specifications for diagnosis
2.6.3 Pathological diagnosis report
3.Pathological type and stage of lung cancer
3.1 WHO's 2021 standard
3.1.1 Squamous cell carcinoma
3.1.2 Adenocarcinoma
3.1.3 Neuroendocrine carcinoma
3.1.4 Other types of lung cancer
3.1.5 Immunohistochemistry and special staining
3.2 Stage of lung cancer

机标关键词：national、english、cancer、china、diagnosis、guidelines、lung、treatment、version

所属期刊栏目：34

分类号：S;H313;G2

在线出版日期：2022-08-09（万方平台首次上网日期，不代表论文的发表时间）

页数：共31页

页码：176-206